Protagonist Therapeutics President and CEO Dinesh V. Patel, Ph.D., filed a Form 4 on November 20, 2026, disclosing a bona fide gift of 300 shares of common stock to a relative on November 19, 2026.
Key Highlights
- Reporting person: Dinesh V. Patel, Ph.D., President and CEO and Director of Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
- Transaction type: Gift (transaction code G) of 300 shares of common stock disposed of at a price of $0.00
- Transaction date: November 19, 2026
- Recipient: The filing describes the transfer as a bona fide gift to a relative of the reporting person
- Remaining direct ownership: 522,668 shares of common stock held directly following the transaction
- Filing signed: Matthew Gosling, Attorney-in-Fact for Dinesh V. Patel, Ph.D., on November 20, 2026
Patel Gift Transaction and Post-Transaction Holdings at Protagonist Therapeutics
According to the Form 4 filed with the SEC, Dinesh V. Patel, Ph.D., who serves as President, CEO, and Director of Protagonist Therapeutics, Inc. (NASDAQ:PTGX), transferred 300 shares of the company's common stock on November 19, 2026. The filing records the transaction under code "G," indicating a gift, and lists the price per share as $0.00. The filing states that "this transaction involves a bona fide gift of securities from the Reporting Person to a relative."
Following the disposition of the 300 gifted shares, the filing reports that Patel directly beneficially owns 522,668 shares of Protagonist Therapeutics common stock. No derivative securities transactions were reported in Table II of the filing. The form was filed on November 20, 2026, the day after the transaction date, and was signed by Matthew Gosling as Attorney-in-Fact for Patel.
The filing does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan. No amendment date was provided, indicating this is an original filing. The reporting person's address is listed as c/o Protagonist Therapeutics, Inc., 7707 Gateway Blvd., Suite 140, Newark, California 94560-1160.
What Was Disclosed
Protagonist Therapeutics CEO Dinesh V. Patel, Ph.D., disclosed a gift of 300 shares of common stock to a relative on November 19, 2026, at $0.00, leaving him with direct beneficial ownership of 522,668 shares.




Please wait processing your request...